The present invention relates to (R)-2-(3-fluoro-4-phenylphenyl)propionic acid (tarenflurbil) or a pharmaceutically acceptable salt, solvate or ester thereof for use in the treatment of inflammation and/or itching of the skin as well as a pharmaceutical composition comprising tarenflurbil.